Home › Funds › Renaissance Technologies › BOLD
Renaissance Technologies position in BOLD
BOUNDLESS BIO INC · Health Care
Latest position (Q2 2026)471.57K sh
Reported value held$1.18M
Portfolio Weight0.00%
First reportedQ2 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 45.38K | $175.63K | New |
| Q3 2024 | 28.70K | $99.59K | Reduce |
| Q1 2025 | 14.40K | $21.74K | New |
| Q1 2025 | 14.40K | $21.74K | New |
| Q2 2025 | 121.00K | $122.21K | Add |
| Q2 2025 | 121.00K | $122.21K | Add |
| Q3 2025 | 223.56K | $274.98K | Add |
| Q4 2025 | 341.40K | $409.68K | Add |
| Q1 2026 | 399.00K | $438.90K | Add |
| Q2 2026 | 471.57K | $1.18M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BOLD
- Fidelity Management & Research (FMR) 2.58M sh · $6.45M · Q2 2026
- Wellington Management Group 556.23K sh · $1.39M · Q2 2026
- Millennium Management 478.64K sh · $1.20M · Q2 2026
- Vanguard Group 662.76K sh · $795.31K · Q4 2025
- Citadel Advisors 145.05K sh · $362.62K · Q2 2026
- Geode Capital Management 116.74K sh · $291.84K · Q2 2026
- BlackRock Inc 88.50K sh · $221.24K · Q2 2026
- Northern Trust Corp 34.82K sh · $87.06K · Q2 2026
- Morgan Stanley 13.00K sh · $32.50K · Q2 2026
- JPMorgan Chase & Co 179 sh · $439 · Q2 2026
- UBS Group AG 2 sh · $5 · Q2 2026